Baird Medical Investment Holdings Limited (BDMD) Revenue History
Annual and quarterly revenue from 2019 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
BDMD Revenue Growth
BDMD Revenue Analysis (2019–2024)
As of May 8, 2026, Baird Medical Investment Holdings Limited (BDMD) generated trailing twelve-month (TTM) revenue of $48.6 million. The most recent quarter (Q4 2024) recorded $23.9 million in revenue, up 81.9% sequentially.
Looking at the longer-term picture, BDMD's 5-year compound annual growth rate (CAGR) stands at +24.8%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $37.0 million in 2024, representing a new all-time high.
When compared to Healthcare sector peers including NVCR (+8.5% YoY), ARAY (-7.9% YoY), and AEYE (+14.5% YoY). Compare BDMD vs NVCR →
BDMD Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| BDMDCurrent | $49M | - | +24.8% | 41.4% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 ARAY | $459M | -7.9% | +3.7% | 1.7% | |
 AEYE | $40M | +14.5% | +14.5% | -7.9% | |
 ELMD | $64M | +15.5% | +14.5% | 15.1% | |
 HLIT | $679M | +1.9% | +11.0% | 9.3% |
BDMD Historical Revenue Data (2019–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $37.0M | +17.7% | $32.7M | 88.2% | $15.3M | 41.4% |
| 2023 | $31.5M | -10.4% | $27.2M | 86.6% | $11.9M | 37.7% |
| 2022 | $35.1M | +26.6% | $28.0M | 79.9% | $13.6M | 38.8% |
| 2021 | $27.7M | +53.0% | $23.2M | 83.6% | $11.9M | 43.0% |
| 2020 | $18.1M | +48.4% | $15.6M | 86.1% | $9.9M | 54.4% |
| 2019 | $12.2M | - | $10.9M | 89.4% | $5.6M | 45.9% |
See BDMD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BDMD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BDMD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBDMD — Frequently Asked Questions
Quick answers to the most common questions about buying BDMD stock.
Is BDMD's revenue growth accelerating or slowing?
BDMD TTM revenue: $49M. YoY growth: N/A. 5-year CAGR: +24.8%.
What is BDMD's long-term revenue growth rate?
Baird Medical Investment Holdings Limited's 5-year revenue CAGR of +24.8% reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is BDMD's revenue distributed by segment?
BDMD reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2024 are available for download. Segment mix reveals concentration and diversification trends.